150 related articles for article (PubMed ID: 8969186)
1. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants.
Sviridov D; Pyle LE; Fidge N
J Biol Chem; 1996 Dec; 271(52):33277-83. PubMed ID: 8969186
[TBL] [Abstract][Full Text] [Related]
2. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.
Sviridov D; Pyle LE; Jauhiainen M; Ehnholm C; Fidge NH
J Lipid Res; 2000 Nov; 41(11):1872-82. PubMed ID: 11060357
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux.
Gillotte KL; Davidson WS; Lund-Katz S; Rothblat GH; Phillips MC
J Biol Chem; 1996 Sep; 271(39):23792-8. PubMed ID: 8798607
[TBL] [Abstract][Full Text] [Related]
5. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
Sviridov D; Pyle L; Fidge N
Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
[TBL] [Abstract][Full Text] [Related]
7. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI
J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454
[TBL] [Abstract][Full Text] [Related]
8. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol.
Davidson WS; Gillotte KL; Lund-Katz S; Johnson WJ; Rothblat GH; Phillips MC
J Biol Chem; 1995 Mar; 270(11):5882-90. PubMed ID: 7890719
[TBL] [Abstract][Full Text] [Related]
9. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles.
Liu L; Bortnick AE; Nickel M; Dhanasekaran P; Subbaiah PV; Lund-Katz S; Rothblat GH; Phillips MC
J Biol Chem; 2003 Oct; 278(44):42976-84. PubMed ID: 12928428
[TBL] [Abstract][Full Text] [Related]
10. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
Huang W; Sasaki J; Matsunaga A; Han H; Li W; Koga T; Kugi M; Ando S; Arakawa K
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):210-6. PubMed ID: 10634820
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage.
Burgess JW; Frank PG; Franklin V; Liang P; McManus DC; Desforges M; Rassart E; Marcel YL
Biochemistry; 1999 Nov; 38(44):14524-33. PubMed ID: 10545174
[TBL] [Abstract][Full Text] [Related]
12. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
Huang W; Matsunaga A; Li W; Han H; Hoang A; Kugi M; Koga T; Sviridov D; Fidge N; Sasaki J
Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210
[TBL] [Abstract][Full Text] [Related]
13. Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.
Daniil G; Zannis VI; Chroni A
PLoS One; 2013; 8(6):e67993. PubMed ID: 23826352
[TBL] [Abstract][Full Text] [Related]
14. Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles.
Asztalos B; Zhang W; Roheim PS; Wong L
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1630-6. PubMed ID: 9327755
[TBL] [Abstract][Full Text] [Related]
15. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
16. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1.
Wang N; Silver DL; Costet P; Tall AR
J Biol Chem; 2000 Oct; 275(42):33053-8. PubMed ID: 10918065
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.
Brown BE; Nobecourt E; Zeng J; Jenkins AJ; Rye KA; Davies MJ
PLoS One; 2013; 8(5):e65430. PubMed ID: 23741493
[TBL] [Abstract][Full Text] [Related]
18. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
20. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
